Amsterdam, the Netherlands —  In their quest of creating safe and effective immunotherapy cancer treatments, LUMICKS and LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell Avidity Analyzer. LAVA Therapeutics [...]

GUILDFORD, England: IDBS, a software informatics solution provider for biotech and pharma, today announced the launch of Polar™, establishing a new product category, BioPharma Lifecycle Management (BPLM), aimed at streamlining drug development and manufacturing in biopharma research. The development of biologics is a dynamic process and those who are most successful must be able to [...]

GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology company, a spin-off from South Korean biotech company Tiumbio, seeking antibody-based therapeutics for patients who are suffering from unaddressed incurable and rare diseases. The strategic collaboration [...]

AMINONIR® Portable for on-site raw material and feed analyses from the industry leader No sample preparation necessary Reliable results for customers within minutes Improved ingredient management and feed quality Essen, Germany. Evonik has launched AMINONIR® Portable, a mobile NIR service with a world’s-first feature: amino acid calibrations. AMINONIR® Portable enables the reliable determination of energy, [...]

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology.  These include the release of new improvements in PromethION flow cells that have enabled a new 10 Terabase sequencing record, modal single-read accuracy of 99.1% using a new sequencing chemistry currently in development, high accuracy variant calling tools and automation options for nanopore sequencing experiments at any scale. Further [...]

- Supporting drug development research through the use of HCA and three-dimensional culture models - Tokyo, Japan - Yokogawa Electric Corporation (TOKYO: 6841) announces that it has entered into a partnership agreement with InSphero AG, a pioneer in the development of 3D in vitro*1 technologies for drug discovery and safety. The two companies aim to establish [...]

REDWOOD CITY, Calif. -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the pricing of its initial public offering of 9,210,527 shares of Class A common stock at a public offering price of $19.00 per share. All of [...]

CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has launched an Air-Dryable RT-qPCR Mix, driving innovation in the development of molecular tests with ambient temperature stability. This specialized master mix is designed for air-drying, a cost-effective and easier alternative [...]

Simplify drug efficacy and neurotoxicity evaluation TOKYO, Japan - Ricoh Co., Ltd. (Tokyo, Japan) and Elixirgen Scientific, Inc. (Baltimore, Maryland, USA) have jointly developed assay-ready cell plates, which may dramatically simplify the drug efficacy testing for neurological diseases and the neurotoxicity testing for chemical compounds. This product contains human neurons generated from human induced pluripotent stem [...]

Positioning Australia at the forefront of healthcare innovation The Victorian Government collaborated with the University of Melbourne and Illumina to secure a $60 million investment for a world-leading genomics hub in Victoria called the Illumina–University of Melbourne Genomics Hub. This collaboration puts Victoria, the University of Melbourne’s researchers, students, and precinct partners at the forefront [...]